Image credit: Testing a health device while reviewing results on a smartphone at a medical office, by nenadstojkovicart, via flickr, licensed CC BY 2.0.
Peptide therapy is increasingly available through biohacking and longevity clinics, but access does not equal standardization. Unlike regulated pharmaceutical treatments, peptides are often used off-label, making the quality of the clinical intake process a critical factor in safety and appropriateness.
For patients researching options, the difference between a credible clinic and a transactional provider often lies in the details of the initial consultation and lab evaluation. This article outlines what to expect from a medically grounded intake for peptide therapy—focusing on patient screening, lab review, and clinical decision-making.
Medical Intake: More Than a Checklist
A proper medical intake for peptide therapy should resemble a clinical assessment, not a formality. At minimum, it should include:
- A detailed personal and family medical history
- Current medication and supplement list
- Known allergies or adverse reactions
- Lifestyle factors (sleep, exercise, alcohol, smoking)
- Mental health screening
- Discussion of treatment goals and expectations
The purpose is not just data collection but clinical context. Peptides like BPC-157, TB-500, or CJC-1295 may affect different systems, and pre-existing conditions—such as cancer risk, autoimmune disorders, or cardiovascular issues—can influence whether therapy is appropriate.
A red flag is a clinic that skips physician-led discussion or allows self-prescribing via online questionnaires. Even in concierge or direct-to-consumer models, a licensed provider should review the intake and make the final determination.
Lab Review: Context Over Isolation
Lab work is often used to justify or guide peptide use, but not all labs are interpreted the same way.
A credible clinic will:
- Require recent, comprehensive bloodwork (typically within 3–6 months)
- Use CLIA-certified or equivalent labs
- Review results in context with symptoms and history
- Avoid overinterpreting minor fluctuations as clinical issues
Peptides are sometimes marketed as solutions to 'optimize' lab markers—like IGF-1 or inflammation panels. But isolated values do not dictate treatment. A responsible provider will explain why a result matters, whether it’s clinically significant, and how it relates (or doesn’t) to a proposed protocol.
Ask: Does the provider explain the limitations of the labs? Do they acknowledge when data is inconclusive? These are signs of medical integrity.
Avoid clinics that use lab panels primarily as a sales tool, especially if they suggest peptides based on minor deviations without clinical symptoms.
Patient Screening: Identifying Contraindications
Peptides are not for everyone. A credible clinic conducts patient screening to identify contraindications and assess risk.
Key screening practices include:
- Evaluating history of malignancy or uncontrolled growth disorders
- Assessing autoimmune conditions
- Screening for pregnancy or breastfeeding
- Reviewing use of other regenerative agents (e.g., growth hormones, stem cells)
Some peptides influence cell proliferation or immune activity. While research is ongoing, clinical caution is warranted in high-risk populations.
The absence of formal screening—such as skipping cancer history or not documenting informed consent—should raise concerns. So should clinics that guarantee outcomes or downplay risks.
Screening also includes setting realistic expectations. Peptide therapy may support recovery or metabolic function, but it is not a cure-all. A provider who spends time discussing uncertainties and unknowns is more likely to be operating within a medical framework than a marketing one.
The Consultation: Who’s Leading the Conversation?
The consultation is where process meets practice. A credible clinic ensures that:
- A licensed medical provider (physician, nurse practitioner, or physician assistant) leads the discussion
- There is time to ask questions and review risks
- The provider explains the rationale for choosing a specific peptide
- Dosing, delivery method, and monitoring are clearly outlined
Be cautious of clinics where the consultation is delegated entirely to coaches, wellness advisors, or unlicensed staff. While support roles are valid, medical decision-making should involve clinical training.
Also pay attention to documentation. A proper intake results in a medical record, not just a checklist. You should receive a summary of the plan, including follow-up and lab retesting schedules.
How to Compare Clinics Using This Framework
When reviewing clinics in The Biohacking Map directory, use these questions to assess intake quality:
- Is a licensed provider involved in the intake and decision-making?
- Do they require recent lab work from accredited labs?
- Is patient history collected in depth, not just for formality?
- Do they screen for contraindications, especially cancer or autoimmune history?
- Is the consultation structured, documented, and medically justified?
These factors won’t guarantee results—but they do indicate whether a clinic follows medical norms. In a field with limited oversight, process is one of the few reliable proxies for credibility.
Use the directory to compare how clinics describe their intake, who leads consultations, and what they require before starting therapy. Look for transparency, not promises.